Burst CME™ in Gaucher Disease: Patient Evaluation and Management

Release Date: December 23, 2025

Expiration Date: December 23, 2026

Activity Overview

Given its complex presentation, Gaucher disease—a rare lysosomal storage disease with varying consequences across its subtypes—is frequently misdiagnosed or diagnosed with delay. In this program, a hematologist provides an overview of recent guidelines and expert recommendations on the diagnosis of Gaucher disease and its management with enzyme replacement and substrate reduction therapy, with a particular focus on type 1 disease.

Target Audience

Hematologists, geneticists, Gaucher specialists, orthopedists, specialty advanced practice providers, and primary care providers.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

• Outline diagnostic criteria to identify patients with Gaucher disease
• Assess the latest efficacy and safety data for current treatments for Gaucher disease

The staff of Physicians’ Education Resource^®, LLC have no relevant financial relationships with ineligible companies.

PER^® mitigated all conflict of interest for faculty, staff, and planners prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER^® or any company that provided commercial support for this activity.